Table of Contents Author Guidelines Submit a Manuscript
International Journal of Photoenergy
Volume 2014 (2014), Article ID 483750, 7 pages
http://dx.doi.org/10.1155/2014/483750
Research Article

Safety Study of Photodynamic Therapy Using Talaporfin Sodium in the Pancreas and Surrounding Tissues in the Syrian Golden Hamster

1National Medical Laser Centre, Division of Surgery and Interventional Science, University College London Medical School, London, UK
2UCL Institute for Liver and Digestive Health, University College London Medical School, London, UK

Received 5 November 2013; Accepted 4 January 2014; Published 25 February 2014

Academic Editor: Victor Loschenov

Copyright © 2014 Johannes Wittmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, A. Thomas, T. Murray, and M. Thun, “Cancer statistics, 2002,” CA-A Cancer Journal for Clinicians, vol. 52, no. 1, pp. 23–47, 2002. View at Google Scholar · View at Scopus
  2. D. M. Parkin, P. Pisani, and J. Ferlay, “Global cancer statistics,” CA-A Cancer Journal for Clinicians, vol. 49, no. 1, pp. 33–64, 1999. View at Google Scholar · View at Scopus
  3. T. J. Kinsella, Y. Seo, J. Willis et al., “The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU—based concurrent chemotherapy for resectable pancreatic cancer,” The American Journal of Clinical Oncology, vol. 31, no. 5, pp. 446–453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Eeson, N. Chang, C. E. McGahan et al., “Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas,” HPB, vol. 14, no. 5, pp. 310–316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Turrini, F. Paye, P. Bachellier et al., “Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association,” European Journal of Surgical Oncology, vol. 39, no. 2, pp. 171–178, 2013. View at Publisher · View at Google Scholar
  6. J. He, B. H. Edil, J. L. Cameron et al., “Young patients undergoing resection of pancreatic cancer fare better than their older counterparts,” Journal of Gastrointestinal Surgery, vol. 17, no. 2, pp. 339–344, 2013. View at Publisher · View at Google Scholar
  7. H. A. Burris III, M. J. Moore, J. Andersen et al., “Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial,” Journal of Clinical Oncology, vol. 15, no. 6, pp. 2403–2413, 1997. View at Google Scholar · View at Scopus
  8. T. Conroy, F. Desseigne, M. Ychou et al., “FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer,” New England Journal of Medicine, vol. 364, no. 19, pp. 1817–1825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Glimelius, K. Hoffman, P.-O. Sjödén et al., “Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer,” Annals of Oncology, vol. 7, no. 6, pp. 593–600, 1996. View at Google Scholar · View at Scopus
  10. D. D. Von Hoff, T. Ervin, F. P. Arena et al., “Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine,” The New England Journal of Medicine, vol. 369, no. 18, pp. 1691–1703, 2013. View at Publisher · View at Google Scholar
  11. R. H. Hawes, Q. Xiong, I. Waxman, K. J. Chang, D. B. Evans, and J. L. Abbruzzese, “A multispecialty approach to the diagnosis and management of pancreatic cancer,” The American Journal of Gastroenterology, vol. 95, no. 1, pp. 17–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sant, C. Allemani, M. Santaquilani, A. Knijn, F. Marchesi, and R. Capocaccia, “EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary,” European Journal of Cancer, vol. 45, no. 6, pp. 931–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Kuroda, T. Kumagi, T. Yokota et al., “Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1, 082 patients,” BMC Gastroenterology, vol. 13, article 134, 2013. View at Publisher · View at Google Scholar
  14. J. Luo, L. Xiao, C. Wu, Y. Zheng, and N. Zhao, “The incidence and survival rate of population-based pancreatic cancer patients: shanghai cancer registry 2004–2009,” PLoS ONE, vol. 8, no. 10, Article ID e76052, 2013. View at Google Scholar
  15. Z. Gong, E. A. Holly, and P. M. Bracci, “Survival in population-based pancreatic cancer patients: San Francisco Bay Area, 1995–1999,” The American Journal of Epidemiology, vol. 174, no. 12, pp. 1373–1381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. P. Cronin-Fenton, R. Erichsen, F. V. Mortensen, S. Dikinis, M. Nørgaard, and J. Jacobsen, “Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population based cohort study,” Clinical Epidemiology, vol. 3, supplement 1, pp. 19–25, 2011. View at Google Scholar · View at Scopus
  17. S. G. Bown, A. W. R. Hatfield, A. Z. Rogowska et al., “Photodynamic therapy for cancer of the pancreas,” Gut, vol. 50, no. 4, pp. 549–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Lustig, T. J. Vogl, D. Fromm et al., “A multicenter phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors,” Cancer, vol. 98, no. 8, pp. 1767–1771, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Mlkvy, H. Messman, A. J. MacRobert et al., “Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC),” British Journal of Cancer, vol. 76, no. 6, pp. 713–718, 1997. View at Google Scholar · View at Scopus
  20. J. Usuda, H. Tsutsui, H. Honda et al., “Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy,” Lung Cancer, vol. 58, no. 3, pp. 317–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kujundžić, T. J. Vogl, D. Stimac et al., “A phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer,” Journal of Surgical Oncology, vol. 96, no. 6, pp. 518–524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mlkvy, H. Messmann, M. Pauer et al., “Distribution and photodynamic effects of meso-tetrahydroxyphenylclhlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster,” British Journal of Cancer, vol. 73, no. 12, pp. 1473–1479, 1996. View at Google Scholar · View at Scopus
  23. J. Regula, B. Ravi, J. Bedwell, A. J. MacRobert, and S. G. Bown, “Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cance—Prolonged animal survival,” British Journal of Cancer, vol. 70, no. 2, pp. 248–254, 1994. View at Google Scholar · View at Scopus
  24. T. Schroder, I.-W. Chen, M. Sperling, R. H. Bell Jr., K. Brackett, and S. N. Joffe, “Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma,” Journal of Surgical Oncology, vol. 38, no. 1, pp. 4–9, 1988. View at Google Scholar · View at Scopus
  25. H. Barr, C. J. Tralau, P. B. Boulos, A. J. MacRobert, R. Tilly, and S. G. Bown, “The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury,” Photochemistry and Photobiology, vol. 46, no. 5, pp. 795–800, 1987. View at Google Scholar · View at Scopus
  26. L. Ayaru, J. Wittmann, A. J. MacRobert, M. Novelli, S. G. Bown, and S. P. Pereira, “Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster,” Pancreatology, vol. 7, no. 1, pp. 20–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. T. Huggett, M. Jermyn, A. Gillams et al., “Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer,” British Journal of Cancer. In press.